G V Prasad, Chairman and CEO of Dr Reddy’s Laboratories Ltd has described the deal for acquisition of Ranbaxy by Sun Pharmaceuticals Industries as a "great move''.
In a statement released here on Monday, Prasad said: "Great move by Sun. Consistent with their strategy of acquiring distressed assets and turning them around.’’
Sun Pharma announced today that it has entered into an agreement to buy out Ranbaxy Laboratories Ltd for $4 billion.